While NOD1 and NOD2 have been demonstrated to alter systemic metabolic phenotypes (e.g., obesity, insulin sensitivity, etc.), there is also evidence that they play a role in cellular metabolic stress signaling. This evidence concerns the gene NOD2 and obesity disorder.